InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →John R Moore, a General Counsel, is a corporate insider tracked by InsiderTape across 1 company. The public record shows 28 open-market SEC Form 4 transactions: 0 purchases worth $0 and 28 sales worth $4.2M, reported from May 16, 22 to Aug 12, 25. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 12, 25 | EWTXEdgewise Therapeutics, Inc. | SELL | 2.1K | $13.39 | $28K |
| May 2, 25 | EWTXEdgewise Therapeutics, Inc. | SELL | 1.9K | $16.45 | $32K |
| Sep 23, 24 | EWTXEdgewise Therapeutics, Inc. | SELL | 20.9K | $27.63 | $578K |
| Sep 20, 24 | EWTXEdgewise Therapeutics, Inc. | SELL | 50.0K | $28.37 | $1.4M |
| May 2, 24 | EWTXEdgewise Therapeutics, Inc. | SELL | 2.0K | $18.91 | $37K |
| Feb 9, 24 | EWTXEdgewise Therapeutics, Inc. | SELL | 8.0K | $20.01 | $161K |
| Feb 8, 24 | EWTXEdgewise Therapeutics, Inc. | SELL | 3.8K | $20.01 | $76K |
| Feb 7, 24 | EWTXEdgewise Therapeutics, Inc. | SELL | 18.0K | $20.00 | $360K |
| Dec 27, 23 | EWTXEdgewise Therapeutics, Inc. | SELL | 8.5K | $10.50 | $89K |
| May 2, 23 | EWTXEdgewise Therapeutics, Inc. | SELL | 1.9K | $8.90 | $17K |
| Oct 3, 22 | EWTXEdgewise Therapeutics, Inc. | SELL | 4.7K | $9.76 | $46K |
| Sep 6, 22 | EWTXEdgewise Therapeutics, Inc. | SELL | 2.4K | $10.99 | $26K |
| Aug 3, 22 | EWTXEdgewise Therapeutics, Inc. | SELL | 9.2K | $9.31 | $86K |
| Jul 6, 22 | EWTXEdgewise Therapeutics, Inc. | SELL | 1.0K | $8.54 | $9K |
| Jul 5, 22 | EWTXEdgewise Therapeutics, Inc. | SELL | 8.2K | $8.35 | $68K |
| Jun 21, 22 | EWTXEdgewise Therapeutics, Inc. | SELL | 31.1K | $7.29 | $227K |
| Jun 17, 22 | EWTXEdgewise Therapeutics, Inc. | SELL | 22.1K | $6.62 | $146K |
| Jun 16, 22 | EWTXEdgewise Therapeutics, Inc. | SELL | 14.7K | $6.17 | $91K |
| Jun 15, 22 | EWTXEdgewise Therapeutics, Inc. | SELL | 18.1K | $6.11 | $110K |
| Jun 14, 22 | EWTXEdgewise Therapeutics, Inc. | SELL | 3.6K | $6.02 | $22K |
| Jun 13, 22 | EWTXEdgewise Therapeutics, Inc. | SELL | 4.1K | $6.01 | $25K |
| Jun 10, 22 | EWTXEdgewise Therapeutics, Inc. | SELL | 7.1K | $6.05 | $43K |
| Jun 9, 22 | EWTXEdgewise Therapeutics, Inc. | SELL | 7.6K | $6.49 | $49K |
| Jun 8, 22 | EWTXEdgewise Therapeutics, Inc. | SELL | 12.6K | $6.63 | $83K |
| Jun 7, 22 | EWTXEdgewise Therapeutics, Inc. | SELL | 17.1K | $6.61 | $113K |
| Jun 6, 22 | EWTXEdgewise Therapeutics, Inc. | SELL | 13.9K | $6.03 | $84K |
| Jun 3, 22 | EWTXEdgewise Therapeutics, Inc. | SELL | 15.2K | $6.05 | $92K |
| May 16, 22 | EWTXEdgewise Therapeutics, Inc. | SELL | 10.8K | $7.42 | $80K |